Perlecan regulates Oct-1 gene expression in vascular smooth muscle cells

Molecular Biology of the Cell

Volumn 8, Issue 6, 1997, Pages 999-1011

  Weiser, Mary C M ^a   Grieshaber, Nicole A ^a   Schwartz, Phillip E ^a   Majack, Richard A ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PERLECAN; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; NONHUMAN; PRIORITY JOURNAL; RAT; TRANSCRIPTION REGULATION; VASCULAR SMOOTH MUSCLE;

ANIMALIA;

EID: 0030917911     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.8.6.999     Document Type: Article

References (65)

1. Adams, J.C., and F.M. Watt. (1993). Regulation of development and differentiation by the extracellular matrix. Development 117, 1183-1198.
2. Assoian, R.K., and Sporn, M.B. (1986). Type beta transforming growth factor (TGF-beta) in human platelets: release during platelet degranulation and action on vascular smooth muscle cells. J. Cell Biol. 102, 1217-1223.
3. Au, Y.P., Kenagy, R.D., Clowes, M.M., and Clowes, A.W. (1993). Mechanisms of inhibition by heparin of vascular smooth muscle cell proliferation and migration. Haemostasis 23(suppl 1), 177-182.
4. Benitz, W.E., Kelley, R.T., Anderson, C.M., Lorant, D.E., and Bernfield, M. (1990). Endothelial heparan sulfate proteoglycan. I. Inhibitory effects on smooth muscle cell proliferation. Am. J. Respir. Cell Mol. Biol. 2, 13-24.
5. Bernards, R., Schackleford, G.M., Gerber, M.R., Horowitz, J.M., Friend, S.H., Schartl, M., Bogenmann, E., Rapaport, J.M., T. McGee, and Dryja, T.P. (1989). Structure and expression of the murine retinoblastoma gene and characterization of its encoded protein. Proc. Natl. Acad. Sci. USA 86, 6474-6478.
6. Bernfield, M., Hinkes, M.T., and Gallo, R.L. (1993). Developmental expression of the syndecans: possible function and regulation. Dev. Suppl., 205-212.
7. Campbell, J.H., Rennick, R.E., Kalevitch, S.G., and Campbell, G.R. (1992). Heparan sulfate-degrading enzymes induce modulation of smooth muscle phenotype. Exp. Cell Res. 200, 156-167.
8. Castellot, J.J., Addonizio, M.L., Rosenberg, R.D., and Karnovsky, M.J. (1981). Cultured endothelial cells produce a heparinlike inhibitor of smooth muscle cell growth. J. Cell Biol. 90, 372-379.
9. Chakravarti, S., Horchar, T., Jefferson, B., Laurie, G.W., and Hassell, J.R. (1995). Recombinant domain III of perlecan promotes cell attachment through its RGDS sequence. J. Biol. Chem. 270, 404-409.
10. Chamley-Campbell, J.H., Campbell, G.R., and Ross, R. (1981). Phenotype-dependent response of cultured aortic smooth muscle cells to serum mitogens. J. Cell Biol. 89, 379-383.
11. Cizmeci-Smith, G., Asundi, V., Stahl, R.C., Teichman, L.J., Chernousov, M., Cowan, K., and Carey, D.J. (1992). Regulated expression of syndecan in vascular smooth muscle cells and cloning of rat syndecan core protein cDNA. J. Biol. Chem. 267, 15729-15736.
12. Clowes, A.W., and Karnovsky, M.J. (1977). Suppression by heparin of smooth muscle cell proliferation in injured arteries. Nature 265, 625-626.
13. Cook, C.L., Weiser, M.C.M., Schwartz, P.E., Jones, C.L., and Majack, R.A. (1994). Developmentally timed expression of an embryonic growth phenotype in vascular smooth muscle cells. Circ. Res. 74, 189-196.
14. Couchman, J.R. (1987). Heterogenous distribution of a basement membrane heparan sulfate proteoglycan in rat tissues. J. Cell Biol. 105, 1901-1916.
15. Ferns, G.A., Raines, E.W., Sprugel, K.H., Motani, A.S., Reidy, M.A., and Ross, R. (1991). Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science 253, 1129-1132.
16. Fletcher, C., Heintz, N., and Roeder, R.G. (1987). Purification and characterization of OTF-1, a transcription factor regulating cell cycle expression of a human histone H2b gene. Cell 51, 773-781.
17. Frid, M., Moiseeva, E., and Stenmark, K.R. (1994). Multiple phenotypically distinct smooth muscle cell populations exist in the adult and developing bovine pulmonary arterial media in vivo. Circ. Res. 75, 669-681.
18. Fritze, L.M., Reilly, C.F., and Rosenberg, R.D. (1985). An antiproliferative heparan sulfate species produced by postconfluent smooth muscle cells. J. Cell Biol. 100, 1041-1049.
19. Galis, Z.S., Muszynski, M., Sukhova, G.K., Simon-Morrissey, E., Unemori, E.N., Lark, M.W., Amento, E., and Libby, P. (1994). Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. Circ. Res. 75, 181-189.
20. Glukhova, M., Frid, M., and Koteliansky, V. (1990). Developmental changes in expression of contractile and cytoskeletal proteins in human aortic smooth muscle. J. Biol. Chem. 265, 13042-13046.
21. Hassell, J.R., Robey, P.G., Barrach, H.J., Wilczek, J., Rennard, S.I., and Martin, G.R. (1980). Isolation of a heparan sulfate-containing proteoglycan from basement membrane. Proc. Natl. Acad. Sci. USA 77, 4494-4498.
22. Hayashi, K., Madri, J.A., and Yurchenco, P.D. (1992). Endothelial cells interact with the core protein of basement membrane perlecan through beta 1 and beta 3 integrins: an adhesion modulated by glycosaminoglycan. J. Cell Biol. 119, 945-959.
23. Hedin, U., Bottger, B.A., Forsberg, E., Johansson, S., and Thyberg, J. (1988). Diverse effects of fibronectin and laminin on phenotypic modulation of cultured arterial smooth muscle cells. J. Cell Biol. 107, 307-319.
24. Iozzo, R.V., Cohen, I.R., Grassel, S., and Murdoch, A.D. (1994). The biology of perlecan: the multifaceted heparan sulfate proteoglycan of basement membranes and pericellular matrices. Biochem. J. 302, 625-639.
25. Jarvelainen, H.T., Kinsella, M.G., Wight, T.N., and Sandell, L.J. (1991). Differential expression of small chondroitin/dermatan sulfate proteoglycans, PG-I/biglycan and PG-II/decorin, by vascular smooth muscle and endothelial cells in culture. J. Biol. Chem. 266, 23274-23281.
26. Kleinman, H.K., McGarvey, M.L., Hassell, J.R., Star, V.L., Cannon, F.B., Laurie, G.W., and Martin, G.R. (1986). Basement membrane complexes with biological activity. Biochemistry 25, 312-318.
27. Kohler, T.R., and Jawien, A. (1992). Flow affects development of intimai hyperplasia after arterial injury in rats. Arterioscler. Thromb. 12, 963-971.
28. LaBella, F., Sive, H.L., Roeder, R.G., and Heintz, N. (1988). Cell-cycle regulation of a human histone H2b gene is mediated by the H2b subtype-specific consensus element. Genes Dev. 2, 32-39.
29. Lakin, N.D., Palmer, R., Lillycrop, K.A., Howard, M.K., Burke, L.C., Thomas, N.S.B., and Latchman, D.S. (1995). Down regulation of the octamer binding protein Oct-1 during growth arrest and differentiation of a neuronal cell line. Mol. Brain Res. 28, 47-54.
30. Li, X., Tsa, P., Weider, E.D., Kribben, A., Van Putten, V., Schrier, R.W., and Nemenoff, R.A. (1994). Vascular smooth muscle cell grown on Matrigel, a model of the contractile phenotype with decreased activation of mitogen-activated protein kinase. J. Biol. Chem. 269, 19653-19658.
31. Lin, C.Q., and Bissell, M.J. (1993). Multi-faceted regulation of cell differentiation by extracellular matrix. FASEB J. 7, 737-743.
32. Lindner, V., Majack, R.A., and Reidy, M.A. (1990). Basic fibroblast growth factor stimulates endothelial regrowth in denuded arteries in vivo. J. Clin. Invest. 85, 2004-2008.
33. Majack, R.A., and Bornstein, P. (1984). Heparin and related glycosaminoglycans regulate the secretory phenotype of vascular smooth muscle cells. J. Cell Biol. 99, 1688-1695.
34. Majack, R.A., and Clowes, A.W. (1984). Inhibition of vascular smooth muscle cell migration by heparin-like glycosaminoglycans. J. Cell. Physiol. 118, 253-256.
35. Majack, R.A., Cook, S.C., and Bornstein, P. (1985). Platelet-derived growth factor and heparin-like glycosaminoglycans regulate thrombospondin synthesis and deposition in the matrix by smooth muscle cells. J. Cell Biol. 101, 1059-1070.
36. Majesky, M.W., Giachelli, C., Reidy, M., and Schwartz, S.M. (1992). Rat carotid neointimal smooth muscle cells reexpress a developmentally regulated phenotype during repair of arterial injury. Circ. Res. 71, 759-768.
37. Marcum, J.A., and Rosenberg, R.D. (1984). Anticoagulantly active heparin-like molecules from vascular tissue. Biochemistry 23, 1730-1737.
38. Mosse, P.R., Campbell, G.R., Wang, Z.L., and Campbell, J.H. (1985). Smooth muscle phenotypic expression in human carotid arteries. I. Comparison of cells from diffuse intimai thickenings adjacent to atheromatous plaques with those of the media. Lab. Invest. 53, 556-562.
39. Murdoch, A.D., Liu, B., Schwarting, R., Tuan, R.S., and Iozzo, R.V. (1994). Widespread expression of perlecan proteoglycan in basement membranes and extracellular matrices of human tissues as detected by a novel monoclonal antibody against domain III and by in situ hybridization. J. Histochem. Cytochem. 42, 239-249.
40. Noonan, D.M., Fulle, A., Valente, P., Cai, S., Horigan, Sasaki, M., Yamada, Y., and Hassell, J.R. (1991). The complete sequence of perlecan, a basement membrane heparan sulfate proteoglycan, reveals extensive similarity with laminin A chain, low density lipoprotein receptor, and the neural cell adhesion molecule. J. Biol. Chem. 266, 22939-22947.
41. Noonan, D.M., and Hassell, J.R. (1993). Perlecan, the large low-density proteoglycan of basement membranes: structure and variant forms. Kidney Int. 43, 53-60.
42. Ottlinger, M.E., Pukac, L.A., and Karnovsky, M.J. (1993). Heparin inhibits mitogen-activated protein kinase activation in intact rat vascular smooth muscle cells. J. Biol. Chem. 268, 19173-19176.
43. Owens, G.K. (1995). Regulation of differentiation of vascular smooth muscle cells. Physiol. Rev. 75, 487-517.
44. Pauly, R.R., Passaniti, A., Crow, M., Kinsella, J.L., Papadopoulos, N., Monticone, R., Ladatta, E.G., and Martin, G.R. (1992). Experimental models that mimic the differentiation of vascular cells. Circulation 86(suppl III), 68-73.
45. Pukac, L.A., Ottlinger, M.E., and Karnovsky, M.J. (1992). Heparin suppresses specific second messenger pathways for protooncogene expression in rat vascular smooth muscle cells. J. Biol. Chem. 267, 3707-3711.
46. Rosenfeld, M.G. (1991). POU-domain transcription factors: pou-erful developmental regulators. Genes Dev. 5, 897-907.
47. Ross, R. (1993). The pathogenesis of atherosclerosis: a perspective for the 1990's. Nature 362, 801-809.
48. Ruvkan, G., and Finney, M. (1991). Regulation of transcription and cell identity by POU domain proteins. Cell 64, 475-478.
49. Sage, E.H., and Bornstein, P. (1991). Extracellular proteins that modulate cell-matrix interactions: SPARC, tenascin, and thrombospondin. J. Biol. Chem. 266, 14831-14834.
50. Schmidhauser, C., Casperson, G.F., Myers, C.A., Sanzo, K.T., Bolten, S., and Bissell, M.J. (1992). A novel transcriptional enhancer is involved in the prolactin-and extracellular matrix-dependent regulation of β-casein gene expression. Mol. Biol. Cell 3, 699-709.
51. Scholer, H.R. (1991). Octamania: the POU factors in murine development. Trends Genet. 7, 323-329.
52. Schwartz, S.M., deBlois, D., and O'Brien, E.R.M. (1995). The intima: soil for athersclerosis and restenosis. Circ. Res. 77, 445-465.
53. Simons, M., Leclerc, G.L., Safian, R.D., Isner, J.M., Weir, L., and Baim, D.S. (1993). Relation between activated smooth muscle cells in coronary-artery lesions and restenosis after atherectomy. N. Engl. J. Med. 328, 608-613.
54. Snow, A.D., Bolender, R.P., Wight, T.N., and Clowes, A.W. (1990). Heparin modulates the composition of the extracellular matrix domain surrounding arterial smooth muscle cells. Am. J. Pathol. 137, 313-330.
55. Soussi, T., Caron de Fromentel, C., Breugnot, C., and May, E. (1988). Nucleotide sequence of a cDNA encoding the rat p53 nuclear oncoprotein. Nucleic Acids Res. 16, 11384.
56. Stadler, E., Campbell, J.H., and Campbell, G.R. (1989). Do cultured vascular smooth muscle cells resemble those of the artery wall? If not, why not? J. Cardiovasc. Pharmacol. 14(S6), S1-S8.
57. Streuli, C.H., Schmidhauser, C., Bailey, N., Yurchenco, P., Skubitz, A.P.N., Roskelley, C., and Bissell, M.J. (1995). Laminin mediates tissue-specific gene expression in mammary epithelia. J. Cell Biol. 129, 591-603.
58. Sturm, R.A., Das, G., and Herr, W. (1988). The ubiquitous octamer-binding protein Oct-1 contains a POU-domain with a homeobox subdomain. Genes Dev. 2, 1582-1599.
59. Thyberg, J. (1996). Differentiated properties and proliferation of arterial smooth muscle cells in culture. Int. Rev. Cytol. 169, 183-265.
60. Thyberg, J., and Hultgardh-Nilsson, A. (1994). Fibronectin and the basement membrane components laminin and collagen type IV influence the phenotypic properties of subcultured rat aortic smooth muscle cells differently. Cell Tissue Res. 276, 263-271.
61. Topouzis, S., and Majesky, M.W. (1996). Smooth muscle lineage diversity in the chick embryo. Dev. Biol. 178, 430-445.
62. Tso, J.Y., Sun, X.H., Kao, T.H., Reece, K.S., and Wu, R. (1985). Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene. Nucleic Acids Res. 13, 2485-2502.
63. Weiser, M.C.M., Majack, R.A., Tucker, A., and Orton, E.C. (1995). Static tension is associated with increased smooth muscle cell DNA synthesis in rat pulmonary arteries. Am. J. Physiol. 268, H1133-H1138.
64. Weiser, M.C.M., Grieshaber, S.S., Belknap, J.K., Kinsella, M.G., and Majack, R.A. (1996). Developmental regulation of perlecan gene expression in aortic smooth muscle cells. Matrix Biol. 15, 331-340.
65. Zerivitz, K., and Akusjarvi, G. (1989). An improved nuclear extract preparation method. Gene Anal. Tech. 6, 101-109.